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Downregulation of Aedes aegypti 
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binding protein 7/Kismet by 
Wolbachia and its effect on dengue 
virus replication
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Dengue virus (DENV) is a mosquito-transmitted virus imposing a significant burden on human health 
around the world. Since current control strategies are not sufficient, there is an urgent need to find 
alternative methods to control DENV transmission. It has been demonstrated that introduction of 
Wolbachia pipientis in Aedes aegypti mosquitoes can impede DENV transmission with the mechanism(s) 
not fully understood. Recently, a number of studies have found the involvement of chromodomain 
DNA binding helicases in case of Human Immunodeficiency virus (HIV) and Influenza A virus infection. 
In this study, we have identified three chromodomain helicase DNA binding protein (CHD) genes in Ae. 
aegypti and looked at their response in the case of Wolbachia and DENV infections. Foremost amongst 
them we have found that AeCHD7/Kismet is significantly downregulated in the presence of Wolbachia 
infection only in female mosquitoes. Furthermore, AeCHD7 levels showed significant increase during 
DENV infection, and AeCHD7 depletion led to severe reduction in the replication of DENV. Our data 
have identified AeCHD7 as a novel Ae. aegypti host factor that is important for DENV replication, 
and Wolbachia downregulates it, which may contribute towards the mechanism(s) of limiting DENV 
replication.
Among arboviruses, dengue virus (DENV) is one of the most important flaviviruses having the potential to affect 
two-thirds of the world’s population1,2. DENV is primarily transmitted to humans through the bit of mosquito 
vector Aedes aegypti, leading to dengue infection and potentially dengue haemorrhagic fever3–5. Lack of availabil-
ity of an effective vaccine and proper medical care has narrowed DENV management strategies to vector control. 
One of the strategies used to overcome DENV vector Ae. aegypti is through the application of pesticides, but due 
to their severe consequences on the environment and the emergence of resistance to pesticides, their potential 
application seems bleak in the near future6. Therefore, new strategies for vector control are urgently needed. One 
of the novel options is the use of an endosymbiotic bacterium Wolbachia which has recently been demonstrated 
to limit DENV, West Nile virus (WNV), and Zika virus (ZIKV) replication in Ae. aegypti7–10.
Wolbachia pipientis is an alphaproteobacterium that naturally infects almost 40–60% of insect species11,12. 
This bacterium is maternally transmitted and is usually associated with manipulations of host reproduction, such 
as feminization13 and male killing14, to promote successful colonization of its host species. Wolbachia naturally 
infects several mosquito species, including Aedes albopictus and Culex pipiens15. However, there is no natural 
Wolbachia infection in the case of Ae. aegypti, which is the most notorious vector for several arboviruses. In 
order to exploit Wolbachia’s potential to limit arbovirus transmission, three strains of Wolbachia, wAlbB (from 
Ae. albopictus)16, wMel (from Drosophila melanogaster)17 and wMelPop-CLA (from D. melanogaster)18 have been 
successfully transinfected into Ae. aegypti. Among these three strains, wMel and wMelPop-CLA are the most 
promising ones for virus blocking7–10,19,20. However, the exact mechanism(s) by which Wolbachia blocks viral 
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replication in Ae. aegypti mosquitoes is still elusive. Few studies that have looked into the transcriptional changes 
in Ae. aegypti mosquitoes upon Wolbachia infection have found increased redox and mitochondrial activity along 
with differential serine protease activity21–23. However, very little is known about the role of chromatin remodelers 
in the case of DENV-Aedes-Wolbachia molecular interactions.
Chromodomain helicase DNA binding proteins (CHD) represent a class of ATP-dependent chromatin 
remodelling enzymes that contribute towards invoking changes in the interaction between DNA and nucle-
osomes24, influencing a wide array of cellular processes such as replication, transcription, recombination, repair 
and development25. Members of the CHD family have been found to be involved in replication of Human 
Immunodeficiency virus (HIV) and Influenza A virus26,27. All the CHD protein family members have a pair of 
chromodomains at their N-terminus along with one sucrose non-fermenting (SNF2) domain in the centre25. In 
humans, the CHD family has nine members. These are further classified, on the basis of additional motif features, 
into three subfamilies: CHD1-2 (class I), CHD3-5 (Class II) and CHD 6-9 (class III)25,28. In D. melanogaster, there 
are three well characterized CHD members named CHD129, Mi230 and Kismet/CHD731. CHD1 is essential for 
the fecundity of both males and females and is indirectly involved in transcriptional elongation32, whilst Mi2 
actively participates in transcriptional repression and is vital for expression of heat shock proteins33,34. Drosophila 
Kismet, that is a homolog of human CHD7, mediates transcriptional elongation35. Apart from characterization 
of the CHD family members’ role in development and chromatin modification, very little is known about their 
potential role in host-pathogen interactions.
In this study, we have identified functional homologs of the CHD family members in Ae. aegypti and looked 
at the effect of Wolbachia infection on their expression. There was significant reduction in the expression of all 
CHD family members in the presence of Wolbachia. Furthermore, we found that AeCHD7 is highly induced 
during DENV infection in Ae. aegypti mosquitoes. A silencing assay demonstrated that AeCHD7 is required for 
the efficient replication and virion production of DENV. This study will help to understand the role of AeCHD7 
in DENV-Aedes-Wolbachia interactions.
Results
Screening of the CHD family genes during Wolbachia infection. Three CHD genes were identi-
fied in the Ae. aegypti genome using Vectorbase36. Blastp was run to identify their homologs in D. melanogaster 
and Culex quinquefasciatus, and these were determined as AeCHD1 (AAEL004716) having 58% identity with 
D. melanogaster CHD1 protein (NP_477197.1), AeCHD3 (AAEL013136) that showed 70% identity with D. mel-
anogaster CHD3 protein (AAD17276.1) and AeCHD7 (AAEL002230) showing 58% identity with D. melano-
gaster Kismet/CHD7 protein (NP_001245820.1). qPCR primers were designed for all the three AeCHD family 
members to experimentally validate their expression in Ae. aegypti mosquitoes by RT-qPCR, and the effect of 
Wolbachia (wMelPop) infection on their expression level. For this, we selected two age groups of Ae. aegypti mos-
quitoes, 4-day- and 12-day-old. While expression of all the three AeCHD genes was confirmed in the mosquitoes, 
they were all mostly downregulated in Wolbachia-infected mosquitoes (Fig. 1A–F), except for AeCHD3, which 
was found to be non-significantly upregulated in 4-day-old Wolbachia-infected mosquitoes (Fig. 1C). However, 
AeCHD7 showed the highest change of 2.9-fold downregulation in 4-day-old Ae. aegypti female mosquitoes 
(Fig. 1E), which led us to further characterise the gene.
AeCHD7 is ubiquitously expressed in all mosquito tissues. In order to determine the relative abun-
dance of AeCHD7 across different tissues, the salivary gland, midgut, muscle, ovary and fat body were isolated 
from 3-day-old female Ae. aegypti mosquitoes. Following RT-qPCR detection of AeCHD7 mRNA transcripts, it 
was found that AeCHD7 is ubiquitously expressed in all tissues with the highest expression level in the salivary 
gland, which was 2.1-fold higher than its expression level in the fat body which showed the lowest relative abun-
dance of AeCHD7 transcripts (Fig. 2). These results are consistent with the previous findings which showed that 
AeCHD7 is expressed in all human tissues37.
Specific Wolbachia-mediated downregulation of AeCHD7 in female Ae. aegypti. To find out 
whether Wolbachia-mediated downregulation of AeCHD7 is gender specific, we evaluated the transcript levels of 
AeCHD7 in 4-day-old female and male Ae. aegypti mosquitoes with and without Wolbachia infection. RT-qPCR 
results showed that Wolbachia downregulates AeCHD7 only in female mosquitoes and not in their male counter-
parts (Fig. 3A). This is interesting in the sense that Wolbachia has a gender specific effect on gene expression in the 
mosquitoes. To examine if the effect can consistently be seen in cell lines as well, we cross-validated the AeCHD7 
mRNA expression levels in Ae. aegypti cell lines, Aag2 and Aag2 infected with wMelPop-CLA (Pop) and found a 
similar trend of AeCHD7 transcript downregulation in Wolbachia-infected cells (Fig. 3B).
Furthermore, to evaluate if Wolbachia has a similar effect on the CHD7 gene in its natural host D. melano-
gaster, four 7-day-old male and female flies infected with Wolbachia (wMelPop strain) were examined for the rel-
ative expression of CHD7. RT-qPCR results confirmed that there was no significant change in the level of CHD7 
mRNA in both male and female D. melanogaster flies infected with Wolbachia (Fig. 3C).
AeCHD7 is upregulated upon DENV infection. Considering the virus blocking effect of Wolbachia in 
Ae. aegypti mosquitoes, we examined the transcript levels of AeCHD7 in the context of mosquito-DENV inter-
action. For this, the transcript levels of AeCHD7 in DENV-injected mosquitoes at three different time points of 
2, 6 and 12 days post-infection (dpi) were analysed. To have a more consistent and high success rate of DENV 
infection, mosquitoes were injected rather than orally fed with the virus. The results revealed that there was an 
increase in the AeCHD7 transcript levels upon DENV infection at all the time points (Fig. 4A–C); however, 
the upregulation was only significant at 2 and 12 dpi, which was 2-fold (Fig. 4A) and 4-fold higher than that in 
uninfected mosquitoes (Fig. 4C), respectively. The aforementioned findings were further confirmed in the Ae. 
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aegypti cell line, Aa20. Cells were infected with DENV2 at 0.1 multiplicity of infection (MOI) and were harvested 
at two different time points that were 1 and 5 dpi. RT-qPCR analysis showed significant increase in AeCHD7 
transcript levels in the case of DENV infection at both 1 and 5 dpi (Fig. 4D). Infection was confirmed by relative 
Figure 1. Relative expression of AeCHD genes in uninfected and Wolbachia-infected Ae. aegypti 
mosquitoes. RT-qPCR based quantification of (A,B) AeCHD1, (C,D) AeCHD3, and (E,F) AeCHD7 genes in 
both Wolbachia-infected (Pop) and uninfected (Tet) 4-day-old and 12-day-old female mosquitoes, respectively. 
Error bars represent standard error of mean (SEM) from three biological replicates (*p < 0.05; **p < 0.01).
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quantification of DENV genomic RNA levels, which showed gradual increase in DENV genomic RNA over time 
(Fig. 4E).
AeCHD7 is required for efficient DENV replication. The upregulation of AeCHD7 in DENV-infected 
cells suggested that the gene could be beneficial for the virus. To investigate whether AeCHD7 is required for 
efficient DENV replication, we knocked down AeCHD7 transcripts in Aa20 cells and challenged these cells with 
DENV at 1 MOI for 72 h. The effect of CHD7 knockdown on DENV was evaluated both at the genomic and the 
virion levels using RT-qPCR and plaque assay. RT-qPCR results confirmed ~50% decrease in AeCHD7 mRNA 
level (Fig. 5A), which led to 2-fold reduction in DENV genomic RNA (Fig. 5B). RT-qPCR results were further 
validated with plaque assay, which confirmed reduction in DENV virion production in AeCHD7 knocked down 
cells as compared with dsGFP or mock-transfected Aa20 cells (Fig. 5C). These results indicate that AeCHD7 is 
a host factor that is used by DENV to facilitate its replication in Ae. aegypti female mosquitoes, and Wolbachia 
downregulates AeCHD7 as shown above, which may contribute to restricting DENV replication.
Discussion
There is accumulating experimental evidence showing the effectiveness of Wolbachia in suppressing the repli-
cation of several flaviviruses, including DENV, ZIKV, WNV, and the alphavirus chikungunya virus (CHIKV) in 
both mosquitoes and mosquitoes-derived cell lines8,10,38. Perhaps the most well studied is the case of DENV rep-
lication that is severely compromised in the presence of Wolbachia39–41. However, the exact mechanism(s) of how 
Wolbachia imparts this antiviral effect is not yet fully understood. In this study, we provide experimental evidence 
that chromodomain DNA binding helicase 7 (AeCHD7) is an Ae. aegypti host factor that is exploited by DENV to 
facilitate its replication, and its downregulation by Wolbachia may contribute to limit DENV replication.
Wolbachia is an endosymbiotic bacterium infecting 40–60% of insect species naturally11 by manipulating host 
reproduction12. Despite fitness costs, Wolbachia may benefit its host by blocking a variety of RNA viruses15,42. 
However, Wolbachia has not been found naturally infecting the most notorious vector Ae. aegypti, that is respon-
sible for transmitting multiple viral diseases18. McMeniman et al. transinfected different strains of Wolbachia 
into Ae. aegypti mosquitoes43 and found that they successfully inhibited replication of DENV and CHIKV38. 
Further studies also demonstrated Wolbachia’s ability to block WNV and ZIKV in the mosquito8–10. Wolbachia’s 
potential to be used as an invaluable tool for disease control and prevention represents an increasingly promising 
approach to limit several mosquito-borne viral diseases, and it is fascinating to explore the exact mechanism(s) 
that induce the antiviral effect. Apart from one study shedding light on the effect of Wolbachia infection on the 
global DNA methylation pattern in mosquitoes44, there lies a huge grey area of the role of chromatin remodelers, 
in Wolbachia-host interactions and possibly the Wolbachia-mediated antiviral effect.
CHD proteins represent a class of proteins that belong to SNF2 superfamily of ATP-dependent chromatin 
modifiers. In mammals, there are 1–9 CHD proteins; however, in D. melanogaster, there are only three CHD 
proteins named CHD1, Mi2 and Kismet25. Members of the CHD family are involved in conducting a wide array 
of functions, including ATPase activity to maintain chromosome structure and regulation of heterochromatic 
elements29, nucleosome mobilization45, transcriptional regulation and elongation46–49, and development and dif-
ferentiation31. Despite extensive characterization of CHD family proteins, their role in shaping host-pathogen 
interactions has not been much investigated. Yet, there are few reports supporting the involvement of CHD1 
in the case of influenza A virus, and both CHD1 and CHD2 in the case of HIV as positive regulators26,27. 
Furthermore, RNAi screen carried out in D. melanogaster S2 cells identified the involvement of CHD7/Kismet 
in antimicrobial humoral response50. The aforementioned facts led us to investigate the possible role of the CHD 
family in Wolbachia-Aedes-DENV interactions. Data mining in VectorBase resulted in the identification of three 
potential AeCHD proteins encoded in the Ae. aegypti genome. Protein blast results identified them as AeCHD1, 
AeCHD3/Mi2 and AeCHD7/Kismet. In order to find out whether Wolbachia regulates the AeCHD genes during 
Figure 2. Tissue-specific expression of AeCHD7 in Ae. aegypti mosquitoes. RT-qPCR results of AeCHD7 
transcript levels in the salivary gland, midgut, muscles, ovaries and fat body of 3-day-old tetracycline treated 
female mosquitoes. Error bars represent SEM of the mean in three biological replicates.
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infection, RT-qPCR was performed to examine the transcript levels of all the three AeCHDs with and without 
Wolbachia infection in whole mosquitoes. Our results showed that there was a uniform trend of downregulation 
of the transcript levels of AeCHD genes in Wolbachia-infected mosquitoes (Fig. 1A–F), except those of AeCHD3 
in 4-day-old Wolbachia-infected female mosquitoes, which showed a non-significant upregulation (Fig. 1C). The 
reduction in the CHD genes was more pronounced in 12-day-old mosquitoes, which could be due to increases in 
the Wolbachia load as the mosquitoes ages. In particular, the wMelPop strain is a virulent strain that may cause 
tissue damage and sickness. The reductions in the AeCHD genes at this late stage may not be of benefit in affect-
ing DENV replication. However, AeCHD7 showed the highest fold change reduction (Fig. 1E,F) in both 4- and 
12-day-old Wolbachia-infected mosquitoes, which prompted us to further investigate this gene in the context of 
Wolbachia-Aedes-DENV interactions.
AeCHD7/Kismet belongs to subfamily III of the CHD proteins that comprises CHD5-9 proteins. This subfam-
ily is defined by the presence of two chromodomains at the N-terminus, one SNF2-like ATPase domain located 
in the central region of the protein structure and a Brahma and Kismet (BRK) domain at the C-terminus25. To 
find out whether the Ae. aegypti homolog fulfils this particular protein signature, NCBI conserved domain finder 
Figure 3. Modulation of AeCHD7/Kismet by Wolbachia infection in male and female mosquitoes and flies, 
and mosquito cell lines. (A) RT-qPCR analysis of AeCHD7 transcript levels in 4-day-old female and male 
mosquitoes, both uninfected (Tet) and infected with Wolbachia (Pop). (B) Relative expression of AeCHD7 in 
Aag2 and Aag2 cells infected with wMelPop-CLA (Pop). (C) Relative expression of the D. melanogaster Kismet 
gene in uninfected (Tet) and Wolbachia-infected (Pop) flies. Error bars represent SEM from three biological 
replicates (**p < 0.01; ***p < 0.001; ns, not significant).
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was used to detect the conserved domains51. Results confirmed the presence of all the domains characteristic of 
CHD7/Kismet proteins (Figure S1). Furthermore, in order to check the conservation of CHD7 across species, 
CHD7/Kismet amino acids were retrieved from Uniprot (Figure S2A) and subjected to maximum likelihood 
phylogenetic tree construction. Phylogenetic results showed that Ae. aegypti CHD7 is closely related to that of Cx. 
quinquefasciatus but not to that of D. melanogaster or Homo sapiens (Figure S2B). To find out the tissue-specific 
expression of AeCHD7, RT-qPCR was performed, which revealed that it is ubiquitously expressed across all main 
mosquito tissues (Fig. 2), which is consistent with the findings in humans37.
In this study we found that AeCHD7 was significantly downregulated in Wolbachia-infected mosquitoes. To 
further investigate whether this Wolbachia-mediated downregulation of AeCHD7 in female Ae. aegypti is gender 
specific and can also be seen in its natural host D. melanogaster, RT-qPCR was employed. Interestingly, we found 
that in the presence of Wolbachia AeCHD7 was specifically downregulated in female Ae. aegypti only (Fig. 3A), 
and there was no change in CHD7/Kismet transcript levels in both female and male D. melanogaster with and 
without Wolbachia (Fig. 3C). This difference in Wolbachia-mediated regulation of CHD7/Kismet in Ae. aegypti 
and D. melanogaster may be due to the fact that Wolbachia is a natural symbiont in D. melanogaster with a long 
association, while it has been recently transinfected into Ae. aegypti52. In regards to the mechanism by which 
Wolbachia infection may affect expression of AeCHD7, one can only speculate at this stage as there is very little 
information in regards to how Wolbachia manipulates its host at the molecular level. Only very recently, some 
molecular data have become available showing that Wolbachia infection leads to changes in the transcriptome or 
small RNA profiles of infected mosquitoes23,53. Regulation of host gene expression could be due to components 
secreted from the endosymbiont, including small non-coding RNAs54, or host response to accommodating the 
Figure 4. Expression pattern of AeCHD7 in DENV infected female Ae. aegypti. (A–C) RT-qPCR 
quantification of AeCHD7 transcript levels at 2, 6 and 12 days post DENV infection of female Ae. aegypti 
mosquitoes. (D) Relative transcript levels of AeCHD7 in Aa20 cells infected with 1 MOI of DENV2 analysed 
at 1 and 5 dpi. (E) RT-qPCR quantification of DENV2 genomic RNA in samples used in (D) confirming virus 
infection and replication. Error bars show SEM from three biological replicates (*p < 0.05; ***p < 0.001; 
****p < 0.0001; ns, not significant).
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endosymbiont, in particular in new associations. However, how Wolbachia infection leads to these changes in the 
host remains to be investigated.
Viruses are the master manipulators of their host environment for their own benefit. Recently, it has been 
reported that CHD1 and CHD2 proteins play a pivotal role in the replication of influenza and HIV viruses26,27. 
Both viruses replicate inside the nucleus. Interestingly, it has further been demonstrated that CHD1 interacts with 
RNA polymerase II to facilitate the replication of influenza A virus27. Little is known about the role of CHD7/
Kismet in the context of virus infection. However, the presence of conserved chromodomains and a SNF2 domain 
makes it highly likely that all the CHDs share similar functions25. We were intrigued to find what happens to 
AeCHD7 during DENV infection. RT-qPCR performed in DENV-infected mosquitoes at different time points 
suggested a continuous trend of upregulation during DENV infection (Fig. 4A–C), which points to the fact that it 
might play an important role in DENV replication. To investigate the role of AeCHD7 in DENV replication fur-
ther, AeCHD7 knockdown study was carried out, which revealed that AeCHD7 is vital for DENV replication and 
virion production (Fig. 5A–C). Very few studies that have been carried out on the involvement of CHDs in virus 
replication have predominantly focused on viruses that replicate inside the nucleus. Therefore, the role of CHDs 
in the replication of viruses that multiply in the cytoplasm (such as DENV) is not known. However, it has been 
demonstrated that DENV capsid55,56 and NS5 proteins go inside the nucleus57,58 with NS5 known to be involved 
in disrupting nucleosome formation59. Therefore, these viral proteins may play a role in modulating AeCHD7 
expression during virus infection. While we have found the involvement of AeCHD7 in mosquito-DENV inter-
action, the exact mechanism(s) that govern the interaction need further investigation.
In summary, we have demonstrated that AeCHD7 facilitates DENV replication, and Wolbachia-mediated 
downregulation of AeCHD7 in female Ae. aegypti may contribute to restriction of DENV replication. However, 
this mechanism is highly specific to female Ae. aegypti mosquitoes and does not appear to be a universal mecha-
nism which Wolbachia employs across different hosts to block viral replication.
Figure 5. Depletion of AeCHD7 impairs DENV replication both at the genomic and the virion levels. 
(A) RT-qPCR analysis of Aa20 cells transfected with either no RNA (Mock) or with dsRNA against GFP as a 
control or with dsRNA against AeCHD7. RPS17 was used to normalize the qPCR data. Error bars show SEM from 
three biological replicates (*p < 0.05; **p < 0.01). (B) RT-qPCR analysis of Aa20 cells treated as in (A) followed 
by DENV infection at 1 MOI using DENV-specific primers to quantify viral genomic RNA. Error bars show 
SEM from three biological replicates (**p < 0.01). (C) Viral plaque visualization by in vitro cell plaque assay 
conducted on the supernatant media from cells treated as in (A,B).
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Materials and Methods
Mosquitoes and flies. For Wolbachia studies, mosquitoes had been previously generated by McMeniman 
et al.43 by transinfecting wMelPop-CLA strain of Wolbachia (Pop) into Ae. aegypti embryos, and uninfected 
mosquitoes were obtained through tetracycline (Tet) treatment of the infected mosquitoes43. w1118 fly line stably 
infected with wMelPop-CLA and the tetracycline cured line were generated by Min et al.60 and kindly provided 
by Dr Karyn Johnson from the University of Queensland.
For DENV infection studies, Ae. aegypti eggs were collected in Townsville in August 2015 and reared in insec-
tary at Public Health Virology FSS. Five-day-old Ae. aegypti (F3) were used for the experiments. DENV2 NGC 
strain obtained from Prof. Roy Hall’s Lab (University of Queensland, School of Chemistry & Molecular Biosciences, 
Brisbane, Australia), was diluted in Opti-MEM (GIBCO Life Technologies, Grans Island, NY) supplemented with 
3% foetal bovine serum (FBS, In Vitro Technologies, Australian origin) and intrathoracically injected (200 μ l) 
in 5-day-old mosquitoes at 105.8/mL (102.1 per dose). Mosquitoes were placed into netted 900 mL containers at 
28 °C with light:dark (L:D) 12:12 hours cycle and at high humidity. Mosquitoes were offered 15% honey water 
 ad libitum. Mosquitoes were collected at 2, 6 and 12 dpi for downstream applications.
Cell cultures. Ae. aegypti Aag2 cell line and Aag2 cells infected with wMelPop-CLA, previously described 
by61, were maintained in 1:1 Mitsuhashi-Maramorosch and Schneider’s insect medium (Invitrogen) supple-
mented with 5–10% FBS (Bovogen Biologicals, French origin), while Aa20 cells were maintained in L15 medium 
(Invitrogen) supplemented with 10% tryptose phosphate broth (TPB) and 5% FBS. All mosquito cell lines were 
kept at 28 °C and passaged every 3–4 days.
Vero cells were maintained in OptiMEM medium supplemented with 2% FBS and were kept at 37 °C in the 
presence of 5% CO2.
RT-PCR and qPCR analyses. Total RNA was extracted from mosquitoes (1–5 mosquitoes per biological 
replicate) or flies (1–5 flies per biological replicate) using Qiazol (Qiagen) and then treated with Turbo DNase 
(Ambion) according to the manufacturers’ instructions. 750–1000 ng of total RNA was then used to make the 
1st strand cDNA using Superscript III (Invitrogen) with either oligo-dT primer for cellular transcripts or with 
DENV-qR primer in order to amplify the DENV genomic RNA.
For qPCR, cDNA produced as above was diluted in 1:5 ratios with nuclease free water. 2 μ l of the diluted 
cDNA was used for downstream qPCR reaction. Both forward and reverse gene-specific primers were used to 
amplify the target genes (primer sequences in Table S1), using QuantiFast SYBR Green (Qiagen) in a Rotorgene 
qPCR machine (Qiagen). For Ae. aegypti samples, RPS17 transcript levels were used for the normalization of RNA 
templates, while RPL32 was used for normalization of D. melanogaster samples. Each qPCR reaction was per-
formed in duplicates with at least three biological replicates. All qPCR data were normalized with Qiagen analysis 
templates and were further analysed by Prism 7.0. Unpaired t-test was used to determine statistical significance 
between two individual groups while one-way ANOVA with Tukey’s post-hoc test was performed to find statisti-
cal significance between more than two groups of data.
RNAi-mediated gene silencing. In order to knockdown the AeCHD7 gene for functional analysis in 
DENV life cycle, primers were designed to amplify a 586 bp product from the AeCHD7 gene with the addition of 
the T7 promoter sequences at both ends (Table S1). MEGAscript T7 Transcription kit was then used according 
to the manufacturer’s instructions in order to synthesize dsRNA targeting the AeCHD7 transcripts. A similar 
approach was followed to synthesize dsRNA against GFP RNA. For knockdown experiments, Aa20 cells were 
double transfected with 2–5 μ g of dsRNA per well against the target gene. dsGFP RNA was used as non-specific 
control.
Virus infection and plaque assay. For virus inoculation experiments, Ae. aegypti Aa20 were seeded at 
the density of 3 × 105 cells per well in 12-well plates. Cells were first double transfected with dsRNA against the 
target gene or GFP control and after 6 h cells were infected with DENV2 (New Guinea strain) at a multiplicity of 
infection (MOI) of 1. Media were collected 72 h post-infection for plaque assay.
To perform plaque assay, Vero cells were seeded in a 96-well plate and were allowed to form monolayers. 
Virus containing media from the experiments were serially diluted into 100, 101, 102, 103 dilutions and added 
to Vero cells in duplicates. Cells were incubated with virus at room temperature with continuous shaking on 
shaker for 1 h and then incubated at 37 °C for one additional hour. After 2 h of incubation, media were aspirated 
and an overlay was added to the cells which comprised of 1.5% carboxymethyl cellulose (CMC) and 2.5% FBS in 
Opti-MEM medium (Sigma). Cells were then incubated for 72 h at 37 °C and 5% CO2 and fixed with 80% ice-cold 
acetone in 1X PBS for 20 min at − 20 °C. Plates were then air dried overnight and blocked with 5% skimmed milk 
in 1 × PBST at 37 °C for 30 min. Cells were then incubated with the primary antibody against DENV2-Envelope 
(human) in 1:1000 dilution in 0.1% skimmed milk in 1 × PBST for 2 h at 37 °C as described previously62. Plates 
were washed 3 times with 1 × PBST and incubated with the secondary antibody (IRDye 800 CW goat anti-human 
LICOR) for 1 h at 37 °C. Plates were washed and dried as above and were dried and scanned on the Odyssey 
imager (LI-COR Biosciences) at 41 μ M resolution.
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